Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/20/2012CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
11/20/2012CA2490735C Liquid preparation comprising oligopeptides and etherified cyclodextrin
11/20/2012CA2486944C Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
11/20/2012CA2482687C Treatment of mesothelioma
11/20/2012CA2467365C Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
11/15/2012WO2012155094A1 Formulations of phospholipid comprising omega fatty acids
11/15/2012WO2012155048A1 Liposome-encapsulated hydrogels for use in a drug delivery system
11/15/2012WO2012155027A1 Wound debridement compositions containing seaprose and methods of wound treatment using same
11/15/2012WO2012155021A1 Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor
11/15/2012WO2012154986A1 Implantable polymeric device for sustained release of sufentanil
11/15/2012WO2012154942A2 Ceramide anionic liposome compositions
11/15/2012WO2012154892A1 Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154825A1 Method for imaging a site of arthritis in an animal
11/15/2012WO2012154779A1 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154778A1 Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154774A1 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154771A1 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154770A1 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012WO2012154725A2 Steroid-sparing effects of beta-adrenergic inverse agonists and use thereof
11/15/2012WO2012154704A2 System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
11/15/2012WO2012154563A1 Sustained release paracetamol formulations
11/15/2012WO2012154505A1 Compositions comprising hydrogel particles
11/15/2012WO2012154500A1 Solid compositions containing glycol ether and water
11/15/2012WO2012154483A1 Dry powder fosfomycin/tobramycin formulation for inhalation
11/15/2012WO2012154474A2 Biomaterial composite composition and method of use
11/15/2012WO2012154427A1 Punctal plugs for controlled release of therapeutic agents
11/15/2012WO2012154340A1 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
11/15/2012WO2012154174A1 Methods for treating insomnia
11/15/2012WO2012154122A2 A topical formulation for treatment of hyperkeratotic skin
11/15/2012WO2012154077A1 Pharmaceutical composition for the treatment of tuberculosis and other infections, and method for producing said composition
11/15/2012WO2012154076A1 Antibacterially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012154075A1 Antibacterially active pharmaceutical composition for external use, and method for the production of said composition
11/15/2012WO2012154018A1 Activated, micronized zeolite, method for activating and micronizing same and use thereof as a carrier in pharmaceutical preparations and dietary supplements
11/15/2012WO2012153870A1 Therapeutic material for glaucoma
11/15/2012WO2012153635A1 Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient
11/15/2012WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell
11/15/2012WO2012153606A1 Composite film
11/15/2012WO2012153576A1 Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube
11/15/2012WO2012153396A1 Non-aqueous patch
11/15/2012WO2012153347A2 Oral pharmaceutical composition of olanzapine form 1
11/15/2012WO2012153338A2 Liposomes comprising polymer-conjugated lipids and related uses
11/15/2012WO2012153313A1 Pharmaceutical composition of febuxostat
11/15/2012WO2012153301A1 Formulations for topical use containing lactoferrin, their preparation and use
11/15/2012WO2012153286A1 Polymeric nanoparticles for drug delivery
11/15/2012WO2012153181A1 Pharmaceutical composition comprising pitavastatin or its pharmaceutically acceptable salts
11/15/2012WO2012153110A1 Use of bethanechol for treatment of xerostomia
11/15/2012WO2012152910A1 Novel pharmaceutical formulation
11/15/2012WO2012152709A1 Hydrophobic preparations
11/15/2012WO2012152707A1 Microemulsions
11/15/2012WO2012152636A1 Film-coating apparatus
11/15/2012WO2012152440A1 Composition for modified release comprising ranolazine
11/15/2012WO2012129497A3 Swallowable medication capsule
11/15/2012WO2012128587A3 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
11/15/2012WO2012128520A3 Liquid-type composition for treating gastroesophageal reflux disease
11/15/2012WO2012126966A3 Optimised preparations of highly adaptable aggregates
11/15/2012WO2012125830A3 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
11/15/2012WO2012124966A3 Fentanyl transdermal patch
11/15/2012WO2012122544A3 Protein nanoparticle dispersions
11/15/2012WO2012107765A3 Particle formulation
11/15/2012WO2012106662A3 New agents to treat/prevent amoebiasis
11/15/2012WO2012100109A3 Therapeutic eye drop comprising doxycycline and a stabilizer
11/15/2012WO2012099930A3 Flavonol compositions
11/15/2012WO2012079047A9 Targeting kidney mesangium with nanoparticles of defined diameter
11/15/2012WO2012078831A3 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
11/15/2012WO2012028524A3 Method for producing a tetranectin-apolipoprotein a-i lipid particle, the lipid particle itself and its use
11/15/2012WO2012012184A3 Ophthalmic devices containing chemokine antagonists
11/15/2012WO2011106729A3 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
11/15/2012WO2011066971A3 Transdermal therapeutic system for the administration of peptides
11/15/2012US20120289932 Device and method for combining a treatment agent and a gel
11/15/2012US20120289601 Gastric Retained Gabapentin Dosage Form
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289490 Compositions and methods for enhancing corticosteroid delivery
11/15/2012US20120288567 Opioid Agonist Formulations with Releasable And Sequestered Antagonist
11/15/2012US20120288566 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
11/15/2012US20120288565 Tamper-resistant oral opioid agonist formulations
11/15/2012US20120288564 Interpenetrating polymer network comprising fibrin
11/15/2012US20120288563 Amorphous darunavir
11/15/2012US20120288562 Acid Resistant Capsules
11/15/2012US20120288561 Delayed-release formulation for reducing the frequency of urination and method of use thereof
11/15/2012US20120288560 Methods for the Treatment of CNS-Related Conditions
11/15/2012US20120288559 Organic compounds
11/15/2012US20120288558 Method for administration of pegylated liposomal doxorubicin
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288556 Ceramide anionic liposome compositions
11/15/2012US20120288555 Antiproliferative compositions comprising curcumin analogs and methods of producing and using same
11/15/2012US20120288554 Canfosfamide monotherapy for treating multiple myeloma
11/15/2012US20120288553 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay
11/15/2012US20120288552 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
11/15/2012US20120288551 Implantable Polymeric Device for Sustained Release of Sufentanil
11/15/2012US20120288549 Cosmetic composition containing white ginseng powder
11/15/2012US20120288544 Novel retigabine composition
11/15/2012US20120288543 Wet Granulation Using A Water Sequestering Agent
11/15/2012US20120288542 Solid pharmaceutical dispersions with enhanced bioavailability
11/15/2012US20120288541 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/15/2012US20120288540 Niosomes, freeze-dried powder thereof and their use in treatment
11/15/2012US20120288539 Pharmaceutical composition comprising oligopeptides
11/15/2012US20120288538 Vaccine against neoplastic or cancerous lesions caused by human papilloma virus (hpv), procedures, uses and methods
11/15/2012US20120288537 Active self-healing biomaterial system
11/15/2012US20120288536 Stabilized Stat3 Decoy Oligonucleotides And Uses Therefor
11/15/2012US20120288535 Rare earth nanoparticles
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 2991